Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Maria Jose Carranza-Naval"'
Autor:
Maria Vargas-Soria, Juan Jose Ramos-Rodriguez, Angel del Marco, Carmen Hierro-Bujalance, Maria Jose Carranza-Naval, Maria Calvo-Rodriguez, Susanne J. van Veluw, Alan W. Stitt, Rafael Simó, Brian J. Bacskai, Carmen Infante-Garcia, Monica Garcia-Alloza
Publikováno v:
Fluids and Barriers of the CNS, Vol 19, Iss 1, Pp 1-13 (2022)
Abstract Background While aging is the main risk factor for Alzheimer´s disease (AD), emerging evidence suggests that metabolic alterations such as type 2 diabetes (T2D) are also major contributors. Indeed, several studies have described a close rel
Externí odkaz:
https://doaj.org/article/891d6b65b29642cb94f3798d887e0c99
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-5 (2021)
Abstract Background The described relationship between Alzheimer’s disease (AD) and type 2 diabetes (T2D) and the fact that AD has no succesful treatment has led to the study of antidiabetic drugs that may limit or slow down AD pathology. Main body
Externí odkaz:
https://doaj.org/article/9c04874fdeec4b8998b1143ef4f3c2c6
Autor:
Pilar Alves-Martinez, Isabel Atienza-Navarro, Maria Vargas-Soria, Maria Jose Carranza-Naval, Carmen Infante-Garcia, Isabel Benavente-Fernandez, Angel Del Marco, Simon Lubian-Lopez, Monica Garcia-Alloza
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Germinal matrix-intraventricular hemorrhage (GM-IVH) is the most frequent intracranial hemorrhage in the preterm infant (PT). Long-term GM-IVH-associated sequelae include cerebral palsy, sensory and motor impairment, learning disabilities, or neurops
Externí odkaz:
https://doaj.org/article/eddb490181d54bd5b6bd1d9c338adf58
Autor:
Carmen Hierro-Bujalance, Carmen Infante-Garcia, Angel del Marco, Marta Herrera, Maria Jose Carranza-Naval, Javier Suarez, Pilar Alves-Martinez, Simon Lubian-Lopez, Monica Garcia-Alloza
Publikováno v:
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2020)
Abstract Background Both Alzheimer’s disease (AD) and type 2 diabetes (T2D) share common pathological features including inflammation, insulin signaling alterations, or vascular damage. AD has no successful treatment, and the close relationship bet
Externí odkaz:
https://doaj.org/article/00f7bef2785847faa9641e53cbf2f424
Autor:
Maria Jose Carranza-Naval, Angel del Marco, Carmen Hierro-Bujalance, Pilar Alves-Martinez, Carmen Infante-Garcia, Maria Vargas-Soria, Marta Herrera, Belen Barba-Cordoba, Isabel Atienza-Navarro, Simon Lubian-Lopez, Monica Garcia-Alloza
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
Alzheimer’s disease is the most common form of dementia, and epidemiological studies support that type 2 diabetes (T2D) is a major contributor. The relationship between both diseases and the fact that Alzheimer’s disease (AD) does not have a succ
Externí odkaz:
https://doaj.org/article/2aef7102f7484b0e8f0aab815dffab6e
Autor:
Maria Jose Carranza-Naval, Maria Vargas-Soria, Carmen Hierro-Bujalance, Gloria Baena-Nieto, Monica Garcia-Alloza, Carmen Infante-Garcia, Angel del Marco
Publikováno v:
Biomolecules, Vol 11, Iss 2, p 262 (2021)
Alzheimer’s disease (AD) is the most common cause of dementia. Epidemiological studies show the association between AD and type 2 diabetes (T2DM), although the mechanisms are not fully understood. Dietary habits and lifestyle, that are risk factors
Externí odkaz:
https://doaj.org/article/bc481e1fb346474191ace97c4ee8e54d
Publikováno v:
Alz Res Therapy 13, 112 (2021)
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-5 (2021)
Alzheimer's Research & Therapy
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-5 (2021)
Alzheimer's Research & Therapy
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname
Background The described relationship between Alzheimer’s disease (AD) and type 2 diabetes (T2D) and the fact that AD has no succesful treatment has led to the study of antidiabetic drugs that may limit or slow down AD pathology. Main body Although
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e019fad6980aaf8504d56599c0c6c343
https://hdl.handle.net/10668/17992
https://hdl.handle.net/10668/17992
Autor:
Maria Vargas-Soria, Gloria Baena-Nieto, Maria Jose Carranza-Naval, Carmen Infante-Garcia, Angel del Marco, Carmen Hierro-Bujalance, Monica Garcia-Alloza
Publikováno v:
Biomolecules 2021, 11(2), 262
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname
RODIN: Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Universidad de Cádiz
Biomolecules
Biomolecules, Vol 11, Iss 262, p 262 (2021)
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname
RODIN: Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Universidad de Cádiz
Biomolecules
Biomolecules, Vol 11, Iss 262, p 262 (2021)
Alzheimer’s disease (AD) is the most common cause of dementia. Epidemiological studies show the association between AD and type 2 diabetes (T2DM), although the mechanisms are not fully understood. Dietary habits and lifestyle, that are risk factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ca578c42e396120e57eaf822078ce2b
https://hdl.handle.net/10668/17172
https://hdl.handle.net/10668/17172
Autor:
Marta Herrera, Monica Garcia-Alloza, Simón Lubián-López, Maria Jose Carranza-Naval, Carmen Hierro-Bujalance, Carmen Infante-Garcia, Angel del Marco, Javier Suarez, Pilar Alves-Martinez
Publikováno v:
Alzheimer's Research & Therapy
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2020)
Alzheimer's Research & Therapy (2020) 12:40
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2020)
Alzheimer's Research & Therapy (2020) 12:40
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname
Background Both Alzheimer’s disease (AD) and type 2 diabetes (T2D) share common pathological features including inflammation, insulin signaling alterations, or vascular damage. AD has no successful treatment, and the close relationship between both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebbff4b9ea490dad3f419c4354b2996a
https://doi.org/10.1186/s13195-020-00607-4
https://doi.org/10.1186/s13195-020-00607-4
Autor:
Maria Vargas-Soria, Olga Simó-Servat, Tine Van Bergen, Clara Alice Musi, Ilaria Viganò, Cristina Hernández, Monica Garcia-Alloza, Ingeborg Klaassen, Reiner Schlingemann, Silvia Galbiati, Jean H.M. Feyen, Sarah Scullion, Gianpaolo Zerbini, María Llorián-Salvador, Esmeralda K. Bosma, Karis Little, Angel del Marco, Maria Jose Carranza-Naval, Tiziana Borsello, Rafael Simó, Alan W. Stitt
Publikováno v:
Trends in Endocrinology & Metabolism. 33(1):50-71
Type 2 diabetes (T2D) is associated with multiple comorbidities, including diabetic retinopathy (DR) and cognitive decline, and T2D patients have a significantly higher risk of developing Alzheimer's disease (AD). Both DR and AD are characterized by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::156559a337075a8f38a72dc5ac82bd3f